- Genomics offers promise of precision medicine (drugstorenews.com)
Human Genome Project has unlocked the complex mysteries of the human genome and unleashed a new era in personalized medicine and pharmaceutical research and development…pharmacy retailers must get out in front of that gene-based drug revolution or risk being left behind… potential health benefits of PGx (pharmacogenomics) are huge,.. So, too, is the field’s growth potential as an industry.
- China slowdown for pharma shouldn’t be ignored, WSJ says (fiercepharmaasia.com)
…widely reported slowdown in sales in China noted across most multinational pharma companies deserves a harder look,…sales for the biggest firms…increased by about 5.5% for the year ended the second quarter well below a 9% average in the previous four quarters… slowdown…was blamed on tighter terms and competition in tenders and a shift in the way sales channels work at big hospitals and via doctors.. trends were compounded.. when China…revalued the yuan..
- Pharmacy Schools with Strongest NAPLEX Scores (pharmacytimes.com)
North American Pharmacist Licensure Examination offers a view of the strongest pharmacy programs based on students’ scores. The following schools listed in alphabetical order had a 100% pass rate on first-time attempts at last year’s exam:
- Butler University (111 first-time attempts) Indianapolis, Indiana
- Jefferson University (82 first-time attempts) Philadelphia, Pennsylvania
- Lebanese American University (2 first-time attempts) Lebanon (charter from the state of New York)
- Southwestern Oklahoma State University (38 first-time attempts) Weatherford, Oklahoma
- Union University (46 first-time attempts) Jackson, Tennessee
- University of California, San Diego (54 first-time attempts)
- University of Houston (102 first-time attempts) Texas
- University of Pittsburgh (101 first-time attempts) (Pennsylvania)
- University of Texas at Austin (115 first-time attempts)
- University of Wyoming (42 first-time attempts) Laramie, Wyoming
- Mayo Clinic takes aim at consumer genomics (healthcareitnews.com)
'The digitization of the genome will unleash entrepreneurs and developers'..Center for Individualized Medicine at Mayo Clinic is investing in and partnering with a new startup (Helix), developing tools and technology to put consumers in control of their genomic data…"Genomics is reaching an inflection point in cost, volumes and knowledge, creating a significant opportunity to unlock information that is currently not widely accessible to individuals,"
- J.D. Power survey: Customers satisfied with pharmacies (drugstorenews.com)Pharmacy’s Focus on Customer Satisfaction Sets the Bar for the Healthcare Industry (jdpower.com)
J.D. Power’s 2015 U.S. Pharmacy Study was released Monday, and it highlights that patients remain satisfied with their pharmacies despite myriad changes to the healthcare landscape in recent years…"Pharmacies serve as a benchmark for other entities in the healthcare ecosystem, as they continue to have the highest levels of customer satisfaction in the healthcare industry, demonstrating that focusing on customer satisfaction is good for both patients and businesses."
- ‘Show me’ payments spawn risk-sharing efforts (drugstorenews.com)
Want to be paid in full for your patient care efforts? Prove they’re making a difference. That’s the message health systems and physician groups are getting from government health plans…a shift in federal payments to evidence-based care… spawning new risk-sharing patient-care initiatives…shifting..focus…from traditional fee-for-service…to one of accountability, cost management, collaborative care and a focus on the long-term health and wellness of the patient.
- Walgreens Settles Pharmacist Consultations Lawsuit (pharmacytimes.com)
Walgreens will pay a $500,000 settlement concerning a civil complaint that the retail pharmacy giant was not compliant with California regulations related to pharmacist consultations… noncompliant with rules requiring pharmacists to perform consultations with patients receiving new prescriptions or new dosages…
- Stock slide makes biopharma deals more enticing for Gilead (and everyone else) (fiercepharma.com)
Analysts and investors may have been ready for Gilead Sciences to make an M&A (merger and acquisition) move before now. But with stocks on a slide, they might be glad Gilead hasn't yet… company is sitting on almost $15 billion in liquidity… biotech's stock losses mean deals are lots cheaper now than they were…the company is eyeing all sorts of deals…
- What Pharmacists Need to Know about Managing COPD (pharmacytimes.com)
Kimberly Henderson, MD, JD, medical director for the Health Systems Alliance at CVS Health and regional medical director for MinuteClinic, discusses what pharmacists need to know about managing COPD. (video)
- Big Pharma’s reputation strikes out again, and profit perceptions may be to blame (fiercepharmamarketing.com)
Here we go again. Another public opinion pool (poll) where Big Pharma shows up among the least likable industries or lands near the bottom when it comes to corporate industry reputation.This time it's the monthly Kaiser Family Foundation health tracking poll…While the core of the study focused on consumers' opinions about drug prices, several questions also tallied public sentiment regarding pharma. And it ain't good.